1.46
Precedente Chiudi:
$1.47
Aprire:
$1.47
Volume 24 ore:
76,129
Relative Volume:
2.34
Capitalizzazione di mercato:
$38.41M
Reddito:
$9.06M
Utile/perdita netta:
$-50.39M
Rapporto P/E:
-0.7604
EPS:
-1.92
Flusso di cassa netto:
$5.89M
1 W Prestazione:
+4.29%
1M Prestazione:
+10.19%
6M Prestazione:
+53.68%
1 anno Prestazione:
-26.26%
Lava Therapeutics Nv Stock (LVTX) Company Profile
Nome
Lava Therapeutics Nv
Settore
Industria
Telefono
31 6 3000 3035
Indirizzo
YALELAAN 62, UTRECHT
Confronta LVTX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
LVTX
Lava Therapeutics Nv
|
1.46 | 37.88M | 9.06M | -50.39M | 5.89M | -1.92 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-12 | Downgrade | Leerink Partners | Outperform → Market Perform |
2024-12-11 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
2022-10-25 | Iniziato | H.C. Wainwright | Buy |
2021-04-19 | Iniziato | JP Morgan | Overweight |
2021-04-19 | Iniziato | Jefferies | Buy |
2021-04-19 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Lava Therapeutics Nv Borsa (LVTX) Ultime notizie
Is LAVA Therapeutics N.V. stock a good hedge against inflationFree Stock Market Knowledge Sharing - jammulinksnews.com
LAVA Therapeutics N.V. Stock Analysis and ForecastRapidly growing investment returns - Autocar Professional
What analysts say about LAVA Therapeutics N.V. stockRapid return acceleration - Autocar Professional
The Best Indian Stocks for Portfolio Diversification Professional Stock Selection ToolsFree Wealth Management Insights - Autocar Professional
Best Gold Stocks to Buy AI Stock InsightsExceptional stock performance - Autocar Professional
AgEagle Aerial Systems Inc. Stock Analysis and ForecastSkyrocketing investment returns - jammulinksnews.com
What drives LAVA Therapeutics N.V. stock priceFree Stock Market Trend Analysis - Autocar Professional
Is LAVA Therapeutics N.V. a good long term investmentFree Consultation - jammulinksnews.com
Personalis Inc. Stock Analysis and ForecastMassive stock growth - jammulinksnews.com
Sigachi Industries Limited (SIGACHI) Announces Strategic ShiftFree Trading Psychology Coaching - Autocar Professional
Is Universal Corporation a good long term investmentSuperior trading gains - Autocar Professional
Best Mid Cap Growth Stocks Elite Trader Market TipsPhenomenal trading returns - PrintWeekIndia
TruCap Finance Limited (TRU) Hits 52 Week HighPowerful profit generation - Autocar Professional
Waaree Energies Limited (544277) Quarterly Results Are OutFree Predictions - jammulinksnews.com
What analysts say about ACCO stockRobust investment performance - jammulinksnews.com
What drives Nucor Corporation stock priceFree Market Volatility Navigation Tips - jammulinksnews.com
P500 stockConsistent triple returns - jammulinksnews.com
What analysts say about SARO stockExceptional earning trajectories - jammulinksnews.com
What drives ARGD stock priceExplosive wealth accumulation - jammulinksnews.com
How LAVA Therapeutics N.V. stock performs during market volatilityLow Volatility High Yield Stocks - Newser
Why LAVA Therapeutics N.V. stock attracts strong analyst attentionHigh Return Setup Scanner - Newser
What makes Hurco Companies Inc. stock price move sharplyFree Stock Market Forecasting Tools - Newser
What makes LAVA Therapeutics N.V. stock price move sharplyMassive Gain Ideas - Newser
How C PROCL stock performs during market volatilityFree Stock Market Forums - Newser
Earning from Blockchain Based Digital Wallet ServicesFree Deep Market Trend Analysis - Newser
LAVA Therapeutics Shareholders Approve Key Proposals in Meeting - TipRanks
LAVA Therapeutics NV reports results for the quarter ended March 31Earnings Summary - TradingView
Here's Why We're Watching LAVA Therapeutics' (NASDAQ:LVTX) Cash Burn Situation - Yahoo Finance
LAVA Therapeutics (LVTX) Receives Reiterated Market Perform Rati - GuruFocus
LAVA Reports First Quarter 2025 Financial Results, Provides Business Update - GlobeNewswire
LAVA (LVTX) Pursues Strategic Moves Amid Workforce Restructuring - GuruFocus
LAVA Therapeutics Slashes 30% Workforce, Closes Netherlands Operations Amid Strategic Review - Stock Titan
RNA Editing Market Deep Research 2025-2032 | QIAGEN N.V., ProQR - openPR.com
LAVA Therapeutics Strengthens Balance Sheet with $5.1 Million Repayment Waiver from Netherlands Enterprise Agency - Nasdaq
Lava Therapeutics Nv Azioni (LVTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):